Hers Subscription Model: How the Telehealth Membership Works

This article is part of the PlexusDx Education Hub, our resource on GLP-1 therapies, weight-management protocols, and the genetic variables shaping metabolic care. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Hers and receives no affiliate compensation for describing how its subscription works.

What people usually want to understand about Hers is not a single drug but the membership itself: what recurring access buys, how the clinical relationship is maintained, and how medication reaches the door. This review focuses on the subscription mechanics and closes with the genetic context a recurring plan leaves untouched. Editorial balance, not a buying recommendation. As of April 2026.

The subscription telehealth model, defined

Hers (Hims & Hers Health) delivers care as an ongoing membership rather than a one-time transaction. In this model, a recurring relationship connects a patient to a licensed provider, a prescription pathway, and continued follow-up, all coordinated online. The subscription is the container; the medication is one element inside it. That framing explains why the experience is defined more by the recurring service than by any single fill.

What a Hers membership includes

Programs built on this model generally bundle a virtual clinical evaluation, a written prescription routed to a retail pharmacy for an FDA-approved brand or a 503A compounding pharmacy for a compounded product, and periodic check-ins that support dose titration and side-effect management. What is or is not bundled, and at what recurring fee, is set by the brand and shown on Hers's official website, which is the authoritative place to confirm current terms.

The intake-to-delivery workflow

The path usually runs in four steps: an online intake capturing weight, medical history, and current medications; a licensed clinician's review and, where eligibility is met, a prescription; routing of that prescription to a retail or compounding pharmacy for fulfillment; and ongoing telehealth follow-up. Whether a physician, NP, or PA handles the review, and which pharmacy fills the order, varies by case within this recurring structure.

Ongoing access and cost cadence

Because access is recurring, cost in this model reads as a monthly cadence rather than a single purchase. Across the telehealth GLP-1 market, monthly totals as of April 2026 tend to fall between roughly $200 and $700+, shaped by product, tier, and dispensing route. Terms for refills, changes, and ongoing support are set by the brand, so confirm them on the brand's own site before subscribing.

The genetic layer these programs leave out

A recurring membership does not account for the upstream genetic architecture that shapes how any GLP-1 compound behaves in a given body. Variants in FTO, the fat-mass and obesity-associated gene, along with GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor tied to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose homeostasis) describe the metabolic terrain a clinician is prescribing into. These are pathway-level signals. They do not predict response to any specific medication, but they map the biology beneath the decision, context a telehealth prescription on its own never captures.

PlexusDx provides semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What distinguishes the approach is that upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, GLP1R, MC4R, and TCF7L2 variants that shape baseline appetite-regulation and energy-balance biology. Pairing that profile with the protocol is the test before you invest approach, turning guesswork into an informed conversation with your healthcare provider.

Not affiliated: PlexusDx is not affiliated with Hers and holds no commercial relationship with the companies discussed in this article.

Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.

Disclaimer: This article is educational. PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: explore the Weight Management Protocols for semaglutide and tirzepatide paired with the genetic context most telehealth programs omit. Or begin upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

What does a Hers subscription actually include?

Programs on this model generally bundle a virtual clinical evaluation, a prescription routed to a retail or 503A compounding pharmacy, and periodic follow-up for titration and side effects. Exactly what is bundled, and at what recurring fee, is set by the brand and shown on its own website.

How does the ongoing membership work?

Access is recurring rather than one-time, so the relationship connects you to a provider, a prescription pathway, and continued follow-up over months. Terms for refills, changes, and cancellation are defined by the brand, so review the current membership details on the brand's own site before subscribing.

Does a subscription include genetic context?

No. A recurring telehealth plan does not map your genetics. The Precision Peptide Genetic Test analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that describe baseline GLP-1 biology, upstream context that a subscription providing medication and follow-up does not capture on its own.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education